Aspen gets Merck licensing agreement for experimental HIV pillChristy Santhosh
More news
Bitter pill for pharmacists as risk of liability rises
Fleishman-Hillard Johannesburg 25 Feb 2009
PIASA members welcome government's 13,2% nod
Inzalo Communications 3 Feb 2009
NAMP becomes global member
Write Scene 22 Jan 2009
Cipla Renews with X/procure® for 4th Consecutive Year
Owlhurst Communications 19 Jan 2009
A year of expansion and success for Austell Laboratories
Write Scene 8 Dec 2008
Pharmaceutical companies found to delay access to affordable generics
National Association of Pharmaceutical Manufacture 2 Dec 2008
Pfizer launches global regenerative medicine research unit
Magna Carta 18 Nov 2008
Pfizer presents new approach to pain management
magna Carta 11 Nov 2008
Drug for diabetes may be banned in the US
9 Nov 2008
MabThera continues to improve patient response in rheumatoid arthritis
EvolutionPr 30 Oct 2008
New biotechnology company formed
SIMONSAYS communications 20 Oct 2008
Pfizer launch new drug for neuropathic pain
Magna Carta 18 Oct 2008
Travel vaccines - plan in advance
Jenni Newman Public Relations 18 Oct 2008
Vaccinated Hajj pilgrims have more devotion time
Jenni Newman Public Relations 14 Oct 2008
Pfizer updates its development pipeline
Magna Carta 8 Oct 2008
‘Emerging 8' set to join ‘Big 5' targeted cancer therapy blockbusters
Dr. Tom Gray 3 Oct 2008
Battle for HIV drugs market getting tougher
Mansi Shah 30 Sep 2008
AstraZeneca stamping out counterfeiting
Simonsays Communications 20 Sep 2008
Aspen establishes its international platform for future growth
Shauneen Beukes Communications 16 Sep 2008
Wyeth applauds inclusion of Prevenar in immunisation schedule
InZalo Communications 14 Sep 2008
Questions over move from RX to OTC
11 Sep 2008
